Evidence map›Paper›PMID 41657082›Full record

ArticleEuropean journal of neurology2026

Prevalence and Patterns of Cranial Nerve Involvement in CIDP, Autoimmune Nodopathy, MMN, and Anti-MAG Neuropathy: A Multicenter Korea/UK Study of 582 Patients.

Young Gi Min, Hyunjin Kim, Hee Jo Han, Byeol-A Yoon, Jong Kuk Kim, Woohee Ju, Seok-Jin Choi, Sung-Min Kim, Ki Hoon Kim, Young Nam Kwon and 7 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Young Gi MinDepartment of Neurology, Seoul National University College of Medicine, Seoul, Korea.
Hyunjin KimDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hee Jo HanDepartment of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Byeol-A YoonDepartment of Neurology, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea.
Jong Kuk KimDepartment of Neurology, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea.
Woohee JuDepartment of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0003-0522-1956
Seok-Jin ChoiDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Sung-Min KimDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Ki Hoon KimDepartment of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Young Nam KwonDepartment of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Seung Woo KimDepartment of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-5621-0811
Eun-Jae LeeDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-8047-1029
Young-Min LimDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kabir K NazeerAston Medical School, Aston University, Birmingham, UK.
Yusuf A RajaballyAston Medical School, Aston University, Birmingham, UK.ORCID 0000-0002-7170-8343
Ha Young ShinDepartment of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-4408-8265
Jung-Joon SungDepartment of Neurology, Seoul National University College of Medicine, Seoul, Korea.

Funding

Asan Institute for Life Science, Asan Medical Center 2024IP0071National Research Foundation of Korea RS-2023-00212125National Research Foundation of Korea RS-2025-00553428National Research Foundation of Korea RS-2025-25467802
6 · The paper itself

Abstract

backgroundCranial nerve involvement is a well-recognized feature in Guillain-Barré syndrome (GBS) but remains less well understood in chronic forms of autoimmune neuropathies. Earlier studies of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) were conducted before updated diagnostic criteria and the recognition of autoimmune nodopathy (AN), which may limit the interpretation of their findings.

methodsWe retrospectively analyzed 582 patients with chronic autoimmune neuropathies-CIDP (n = 431), multifocal motor neuropathy (MMN) (n = 64), anti-myelin-associated glycoprotein (MAG) neuropathy (n = 54), and AN (n = 33)-from 4 Korean and 1 UK centers. Patients with cranial nerve involvement were identified and described. CIDP patients with cranial nerve involvement (cranial+ CIDP) were compared with those without (cranial- CIDP).

resultsCranial nerve involvement was observed in 8.8% (38/431) of CIDP and 24.2% (8/33) of AN patients but was absent in MMN (0/64) and anti-MAG neuropathy (0/54). Facial palsy was overall the most common manifestation (CIDP: 45%, AN: 50%). Patients with AN more frequently exhibited bilateral optic neuropathy (50%) and facial diplegia (38%), while CIDP patients more often showed trigeminal neuropathy and oculomotor nerve palsy (both 32%). Compared with cranial- CIDP, cranial+ CIDP patients were more often younger, of variant subtypes (especially multifocal), presented (sub)acutely with preceding infection/vaccination, followed by relapsing-remitting rather than progressive courses, and achieved greater improvement despite greater pre-treatment disability.

conclusionsCranial nerve involvement serves as a diagnostic clue in chronic autoimmune neuropathies, particularly in identifying AN and CIDP. Cranial+ CIDP appears to represent a distinct subset with partial overlap to GBS, suggesting unique underlying mechanisms.

Indexed as

Cranial Nerve DiseasesMyelin-Associated GlycoproteinPolyneuropathiesPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingAdultAgedAged, 80 and overCranial NervesFemaleHumansMaleMiddle AgedPrevalenceRepublic of KoreaRetrospective StudiesUnited KingdomMyelin-Associated GlycoproteinANanti‐MAG neuropathyCIDPcranial nerveMMN

Identifiers

PMID41657082
PMCPMC12884130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.